Development of a gene-activated scaffold platform for tissue engineering applications using chitosan-pDNA nanoparticles on collagen-based scaffolds

Journal of Controlled Release

Volumn 210, Issue , 2015, Pages 84-94

  Raftery, Rosanne M ^a,b   Tierney, Erica G ^a,b   Curtin, Caroline M ^a,b   Cryan, Sally Ann ^a,b   O'Brien, Fergal J ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Chitosan nanoparticles; Gene delivery; Gene activated scaffold; Mesenchymal stem cells (MSCs); Tissue engineering

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; CELL CULTURE; CELL ENGINEERING; CHITIN; CHITOSAN; COLLAGEN; DRUG INTERACTIONS; FLOWCHARTING; GENE THERAPY; GENE TRANSFER; GENES; NANOPARTICLES; PROTEINS; RECOMBINANT PROTEINS; STEM CELLS; TISSUE; TISSUE ENGINEERING;

BIOMATERIAL SCAFFOLDS; CHITOSAN NANOPARTICLES; COLLAGEN-BASED SCAFFOLDS; GENE DELIVERY; MESENCHYMAL STEM CELL; THERAPEUTIC APPLICATION; TISSUE ENGINEERING APPLICATIONS; TRANSFECTION EFFICIENCY;

SCAFFOLDS (BIOLOGY);

CHITOSAN NANOPARTICLE; COLLAGEN; HYALURONIC ACID; HYDROXYAPATITE; LUCIFERASE; PLASMID DNA; POLYETHYLENEIMINE; CHITOSAN; DNA; GREEN FLUORESCENT PROTEIN; NANOPARTICLE;

ARTICLE; CERVICAL CANCER CELL LINE; COMPLEX FORMATION; GENE ACTIVATED COLLAGEN BASED SCAFFOLD; GENE EXPRESSION; GENE TARGETING; GENE VECTOR; GENETIC TRANSFECTION; HEK293 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYMAL STEM CELL; MOLECULAR WEIGHT; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE SCAFFOLD; TRANSGENE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; ESCHERICHIA COLI; GENE TRANSFER; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PLASMID; SPRAGUE DAWLEY RAT;

ANIMALS; CHITOSAN; COLLAGEN; DNA; DURAPATITE; ESCHERICHIA COLI; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HYALURONIC ACID; LUCIFERASES; MALE; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; PLASMIDS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84929623244     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.05.005     Document Type: Article

References (61)

1. B. De la Riva Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration J. Control. Release 143 1 2010 45 52
2. E. Quinlan Development of collagen-hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering J. Control. Release 198 2015 71 79
3. S.N. Khan, and J.M. Lane The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications Expert. Opin. Biol. Ther. 4 5 2004 741 748
4. M. Miyazaki An update on bone substitutes for spinal fusion Eur. Spine J. 18 6 2009 783 799
5. S. Hacein-Bey-Abina Sustained correction of x-linked severe combined immunodeficiency by ex vivo gene therapy N. Engl. J. Med. 346 16 2002 1185 1193
6. R.J. Lee VEGF gene delivery to myocardium deleterious effects of unregulated expression Circulation 102 8 2000 898 901
7. K. Lundstrom, and T. Boulikas Viral and non-viral vectors in gene therapy: technology development and clinical trials Technol. Cancer Res. Treat. 2 5 2003 471 486
8. S. Djurovic Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes Mol. Biotechnol. 28 1 2004 21 31
9. M.A. Kay State-of-the-art gene-based therapies: the road ahead Nat. Rev. Genet. 12 5 2011 316 328
10. D.W. Pack Design and development of polymers for gene delivery Nat. Rev. Drug Discov. 4 7 2005 581 593
11. A. Akinc Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis J. Gene Med. 7 5 2005 657 663
12. E.G. Tierney The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds J. Control. Release 158 2 2012 304 311
13. O. Boussif A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc. Natl. Acad. Sci. 92 16 1995 7297 7301
14. K. Regnström Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for nonviral gene delivery Pharm. Res. 23 3 2006 475 482
15. K. Corsi Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles Biomaterials 24 7 2003 1255 1264
16. F.C. MacLaughlin Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery J. Control. Release 56 1 1998 259 272
17. H.-Q. Mao Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency J. Control. Release 70 3 2001 399 421
18. T. Ishii, Y. Okahata, and T. Sato Mechanism of cell transfection with plasmid/chitosan complexes Biochim. Biophys. Acta Biomembr. 1514 1 2001 51 64
19. N. Csaba, M. Köping-Höggård, and M.J. Alonso Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery Int. J. Pharm. 382 1 2009 205 214
20. R.J. Mumper Novel polymeric condensing carriers for gene delivery Proceedings of the international symposium on controlled release bioactive materials 22 1995 178 179
21. E. Malakooty Poor Chitosan-pDNA nanoparticle characteristics determine the transfection efficacy of gene delivery to human mesenchymal stem cells Artif. Cells Nanomed. Biotechnol. 1 1 2013 1 9
22. S. Mansouri Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy Eur. J. Pharm. Biopharm. 57 1 2004 1 8
23. M. Huang Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation J. Control. Release 106 3 2005 391 406
24. T. Kiang The effect of the degree of chitosan deacetylation on the efficiency of gene transfection Biomaterials 25 22 2004 5293 5301
25. M. Köping-Höggård Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers Gene Ther. 11 19 2004 1441 1452
26. S.P. Strand Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking Biomaterials 31 5 2010 975 987
27. J. Bonadio Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration Nat. Med. 5 7 1999 753 759
28. F.J. O'Brien, J.P. Gleeson, N. Plunkett, Collagen/hydroxyapatite composite scaffold, and process for the production thereof, 2013, Google Patents.
29. T.J. Levingstone A biomimetic multi-layered collagen-based scaffold for osteochondral repair Acta Biomater. 10 5 2014 1996 2004
30. C.M. Curtin Combinatorial Gene therapy accelerates bone regeneration: nonviral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold Adv. Healthc. Mater. 4 2 2014 223 227
31. E.A. Klausner Ultrapure chitosan oligomers as carriers for corneal gene transfer Biomaterials 31 7 2010 1814 1820
32. G. Puras Low molecular weight oligochitosans for non-viral retinal gene therapy Eur. J. Pharm. Biopharm. 83 2 2013 131 140
33. F.J. O'Brien Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds Biomaterials 25 6 2004 1077 1086
34. F.J. O'Brien The effect of pore size on cell adhesion in collagen-GAG scaffolds Biomaterials 26 4 2005 433 441
35. J. Gleeson, N. Plunkett, and F. O'Brien Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone tissue regeneration Eur. Cell Mater. 20 2010 218 230
36. A. Matsiko Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering J. Mech. Behav. Biomed. Mater. 11 2012 41 52
37. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 6.15 1989 Cold Spring Harbor Laboratory Press New York 6 44
38. J.B. Lepecq, and C. Paoletti A fluorescent complex between ethidium bromide and nucleic acids: physical-chemical characterization J. Mol. Biol. 27 1 1967 87 106
39. M.G. Haugh, C.M. Murphy, and F.J. O'Brien Novel freeze-drying methods to produce a range of collagen-glycosaminoglycan scaffolds with tailored mean pore sizes Tissue Eng. Part C 16 5 2010 887 894
40. M.G. Haugh, M.J. Jaasma, and F.J. O'Brien The effect of dehydrothermal treatment on the mechanical and structural properties of collagen-GAG scaffolds J. Biomed. Mater. Res. Part A 89 2 2009 363 369
41. N. Oh, and J.-H. Park Endocytosis and exocytosis of nanoparticles in mammalian cells Int. J. Nanomedicine 9 Suppl. 1 2014 51 63
42. J. Rejman Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis Biochem. J. 377 2004 159 169
43. M. Agirre Low molecular weight chitosan (LMWC)-based polyplexes for pDNA delivery: from bench to bedside Polymers 6 6 2014 1727 1755
44. T. Sato, T. Ishii, and Y. Okahata In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency Biomaterials 22 15 2001 2075 2080
45. A. Hamm Efficient transfection method for primary cells Tissue Eng. 8 2 2002 235 245
46. Z. Garaiova Cellular uptake of DNA-chitosan nanoparticles: the role of clathrin- and caveolae-mediated pathways Int. J. Biol. Macromol. 51 5 2012 1043 1051
47. P. Calvo Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers J. Appl. Polym. Sci. 63 1 1997 125 132
48. M. Köping-Höggård Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo J. Gene Med. 5 2 2003 130 141
49. S.P. Strand Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes Biomacromolecules 6 6 2005 3357 3366
50. M. Lavertu High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation Biomaterials 27 27 2006 4815 4824
51. K. Romøren The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes Int. J. Pharm. 261 1 2003 115 127
52. O. Jeon Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery Biochem. Biophys. Res. Commun. 369 2 2008 774 780
53. D. Schaffert, and E. Wagner Gene therapy progress and prospects: synthetic polymer-based systems Gene Ther. 15 16 2008 1131 1138
54. J.-P. Behr The proton sponge: a trick to enter cells the viruses did not exploit CHIMIA Int. J. Chem. 51 1-2 1997 34 36
55. C. Moreira Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone Acta Biomater. 5 8 2009 2995 3006
56. M. Köping-Höggård Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo Gene Ther. 8 2001 1108 1121
57. M. Thanou Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines Biomaterials 23 1 2002 153 159
58. S.W. Richardson, H.J. Kolbe, and R. Duncan Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA Int. J. Pharm. 178 2 1999 231 243
59. T. Kean, and M. Thanou Biodegradation, biodistribution and toxicity of chitosan Adv. Drug Deliv. Rev. 62 1 2010 3 11
60. C.M. Curtin Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cell-mediated bone formation Adv. Mater. 24 6 2012 749 754
61. C. Xianmiao Properties and in vitro biological evaluation of nano-hydroxyapatite/chitosan membranes for bone guided regeneration Mater. Sci. Eng. C 29 1 2009 29 35